These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 422697)

  • 1. Blood pressure response to an angiotensin II antagonist in patients with acromegaly.
    Ogihara T; Hata T; Maruyama A; Mikami H; Nakamaru M; Okada Y; Kumahara Y
    J Clin Endocrinol Metab; 1979 Jan; 48(1):159-62. PubMed ID: 422697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
    Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
    Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin-aldosterone system in normotensive and hypertensive patients with acromegaly.
    Strauch G; Vallotton MB; Touitou Y; Bricaire H
    N Engl J Med; 1972 Oct; 287(16):795-9. PubMed ID: 4341550
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal adrenal and vascular responses to angiotensin II and an angiotensin antagonist in acromegaly.
    Moore TJ; Thein-Wai W; Dluhy RG; Dawson-Hughes BF; Hollenberg NK; Williams GH
    J Clin Endocrinol Metab; 1980 Aug; 51(2):215-22. PubMed ID: 6995474
    [No Abstract]   [Full Text] [Related]  

  • 6. The diurnal rhythm of plasma aldosterone, plasma renin activity, plasma cortisol and serum growth hormone and subnormal responsiveness of aldosterone to angiotensin-II in the patients with normotensive acromegaly.
    Ichikawa S; Sakamaki T; Tonooka S; Sugai Y
    Endocrinol Jpn; 1976 Feb; 23(1):75-82. PubMed ID: 945156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure response to an angiotensin II antagonist in thyrotoxic patients with and without high blood pressure.
    Ogihara T; Hata T; Maruyama A; Mikami H; Nakamaru M; Naka T; Kumahara Y; Kuma K
    Endocrinol Jpn; 1980 Apr; 27(2):223-7. PubMed ID: 7408785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acromegaly and hypertension: role of the renin-angiotensin-aldosterone system.
    Karlberg BE; Ottosson AM
    Acta Endocrinol (Copenh); 1982 Aug; 100(4):581-7. PubMed ID: 7124280
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of sodium depletion on the renin-angiotensin-aldosterone system and renal prostaglandins in acromegalic patients.
    Zacharieva S; Andreeva M; Andonova K
    Exp Clin Endocrinol; 1990 Nov; 96(2):213-8. PubMed ID: 2097166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonistic activities of isoleucine8-angiotensin II in man.
    Kono T; Taniguchi A; Imura H; Oseko F; Khosla MC
    Endocrinol Jpn; 1985 Oct; 32(5):701-8. PubMed ID: 3912161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the renin-angiotensin-aldosterone system in elderly hypertensive patients with an angiotensin II antagonist.
    Ogihara T; Hata T; Maruyama A; Mikami H; Nakamaru M; Mandai T; Kumahara Y
    Clin Sci (Lond); 1979 Nov; 57(5):461-3. PubMed ID: 519955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A; Shaldon S; Barjon P; Mion C
    Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of exogenous angiotensin II infusion after one year of captopril therapy in essential hypertension.
    Ruilope LM; Miranda B; Robles RG; Hammond TG; Sancho J; Romero JC; Rodicio JL
    Postgrad Med J; 1986; 62 Suppl 1():90-3. PubMed ID: 3534868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body composition, blood pressure and the renin-angiotensin system in acromegaly before and after treatment.
    Davies DL; Beastall GH; Connell JM; Fraser R; McCruden D; Teasdale GM
    J Hypertens Suppl; 1985 Dec; 3(3):S413-5. PubMed ID: 2856753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.